Dec 14, 2022 9:00 am EST Know Labs, Inc. to Host Review of Fiscal Year 2022 Results on December 20, 2022
Nov 07, 2022 9:00 am EST Know Labs Participating in Second Annual Bernstein CGM Disruptors Conference
Sep 20, 2022 12:01 pm EDT Know Labs, Inc. Announces Closing of $8.28 Million Public Offering of Common Stock
Sep 15, 2022 6:02 pm EDT Know Labs, Inc. Announces Pricing of Upsized $7.2 Million Public Offering of Common Stock and Uplisting to the NYSE American Exchange
Sep 02, 2022 9:00 am EDT Know Labs Provides Update on IRB-Approved Internal Trial of Non-Invasive Glucose Monitoring Technology
Aug 03, 2022 9:00 am EDT Know Labs Files S-1 for New Share Offering, Seeks Uplist to NYSE American Exchange